Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 April 2021) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 5MB, 226 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website. 

 

 

Export 46 results:
Author Title Type [ Year(Desc)]
Filters: Author is Van Staa, T.  [Clear All Filters]
1997
T. Van Staa, Abenhaim, L., and Monette, J., “Rates of hypoglycemia in users of sulfonylureas”, J Clin Epidemiol, vol. 50, pp. 735-41, 1997.
T. Van Staa, Abenhaim, L., and Cooper, C., “Upper gastrointestinal adverse events and cyclical etidronate”, Am J Med, vol. 103, pp. 462-7, 1997.
2007
W. Hogler, Wehl, G., Van Staa, T., Meister, B., Klein-Franke, A., and Kropshofer, G., “Incidence of skeletal complications during treatment of childhood acute lymphoblastic leukemia: comparison of fracture risk with the General Practice Research Database”, Pediatr Blood Cancer, vol. 48, pp. 21-7, 2007.
2008
S. Rietbrock, Heeley, E., Plumb, J., and Van Staa, T., “Chronic atrial fibrillation: Incidence, prevalence, and prediction of stroke using the Congestive heart failure, Hypertension, Age >75, Diabetes mellitus, and prior Stroke or transient ischemic attack (CHADS2) risk stratification scheme”, Am Heart J, vol. 156, pp. 57-64, 2008.
2009
M. Gulliford, Latinovic, R., Charlton, J., Little, P., Van Staa, T., and Ashworth, M., “Selective decrease in consultations and antibiotic prescribing for acute respiratory tract infections in UK primary care up to 2006”, J Public Health (Oxf), vol. 31, pp. 512-20, 2009.
2011
M. C. Gulliford, Van Staa, T., McDermott, L., Dregan, A., McCann, G., Ashworth, M., Charlton, J., Grieve, A. P., Little, P., Moore, M. V., and Yardley, L., “Cluster randomised trial in the General Practice Research Database: 1. Electronic decision support to reduce antibiotic prescribing in primary care (eCRT study)”, Trials, vol. 12, p. 115, 2011.
A. Dregan, Grieve, A., Van Staa, T., and Gulliford, M. C., “Potential application of item-response theory to interpretation of medical codes in electronic patient records”, BMC Med Res Methodol, vol. 11, p. 168, 2011.
M. T. Bazelier, Van Staa, T., Uitdehaag, B. M., Cooper, C., Leufkens, H. G., Vestergaard, P., Bentzen, J., and de Vries, F., “The risk of fracture in patients with multiple sclerosis: the UK general practice research database”, J Bone Miner Res, vol. 26, pp. 2271-9, 2011.
2012
K. Bhaskaran, Douglas, I., Evans, S., Van Staa, T., and Smeeth, L., “Angiotensin receptor blockers and risk of cancer: cohort study among people receiving antihypertensive drugs in UK General Practice Research Database”, Bmj, vol. 344, p. e2697, 2012.
A. Dregan, Van Staa, T., McDermott, L., McCann, G., Ashworth, M., Charlton, J., Wolfe, C., Rudd, A., Yardley, L., and Gulliford, M., “Cluster randomized trial in the general practice research database: 2. Secondary prevention after first stroke (eCRT study): study protocol for a randomized controlled trial”, Trials, vol. 13, p. 181, 2012.
C. J. Edwards, Campbell, J., Van Staa, T., and Arden, N. K., “Regional and temporal variation in the treatment of rheumatoid arthritis across the UK: a descriptive register-based cohort study”, BMJ Open, vol. 2, 2012.
M. T. Bazelier, Mueller-Schotte, S., Leufkens, H. G., Uitdehaag, B. M., Van Staa, T., and de Vries, F., “Risk of cataract and glaucoma in patients with multiple sclerosis”, Mult Scler, vol. 18, pp. 628-38, 2012.
2013
E. Herrett, Shah, A. D., Boggon, R., Denaxas, S., Smeeth, L., Van Staa, T., Timmis, A., and Hemingway, H., “Completeness and diagnostic validity of recording acute myocardial infarction events in primary care, hospital care, disease registry, and national mortality records: cohort study”, Bmj, vol. 346, p. f2350, 2013.
I. M. Carey, Atkinson, R. W., Kent, A. J., Van Staa, T., Cook, D. G., and Anderson, H. R., “Mortality associations with long-term exposure to outdoor air pollution in a national English cohort”, Am J Respir Crit Care Med, vol. 187, pp. 1226-33, 2013.
D. F. Carr, O'Meara, H., Jorgensen, A. L., Campbell, J., Hobbs, M., McCann, G., Van Staa, T., and Pirmohamed, M., “SLCO1B1 genetic variant associated with statin-induced myopathy: a proof-of-concept study using the clinical practice research datalink”, Clin Pharmacol Ther, vol. 94, pp. 695-701, 2013.
R. P. Cornish, Boyd, A., Van Staa, T., Salisbury, C., and Macleod, J., “Socio-economic position and childhood multimorbidity: a study using linkage between the Avon Longitudinal Study of Parents and Children and the General Practice Research Database”, Int J Equity Health, vol. 12, p. 66, 2013.
2014
H. O'Meara, Carr, D. F., Evely, J., Hobbs, M., McCann, G., Van Staa, T., and Pirmohamed, M., “Electronic health records for biological sample collection: feasibility study of statin-induced myopathy using the Clinical Practice Research Datalink”, Br J Clin Pharmacol, vol. 77, pp. 831-8, 2014.
M. C. Gulliford, Van Staa, T., Dregan, A., McDermott, L., McCann, G., Ashworth, M., Charlton, J., Little, P., Moore, M. V., and Yardley, L., “Electronic health records for intervention research: a cluster randomized trial to reduce antibiotic prescribing in primary care (eCRT study)”, Ann Fam Med, vol. 12, pp. 344-51, 2014.
A. R. Tate, Beloff, N., Al-Radwan, B., Wickson, J., Puri, S., Williams, T., Van Staa, T., and Bleach, A., “Exploiting the potential of large databases of electronic health records for research using rapid search algorithms and an intuitive query interface”, J Am Med Inform Assoc, vol. 21, pp. 292-8, 2014.
R. P. Cornish, Henderson, J., Boyd, A. W., Granell, R., Van Staa, T., and Macleod, J., “Validating childhood asthma in an epidemiological study using linked electronic patient records”, BMJ Open, vol. 4, p. e005345, 2014.
2015
E. Herrett, Gallagher, A. M., Bhaskaran, K., Forbes, H., Mathur, R., Van Staa, T., and Smeeth, L., “Data Resource Profile: Clinical Practice Research Datalink (CPRD)”, Int J Epidemiol, vol. 44, pp. 827-36, 2015.
K. T. Palmer, Walker-Bone, K., Harris, E. C., Linaker, C., D'Angelo, S., Sayer, A. A., Gale, C. R., Evandrou, M., Van Staa, T., Cooper, C., and Coggon, D., “Health and Employment after Fifty (HEAF): a new prospective cohort study”, BMC Public Health, vol. 15, p. 1071, 2015.
L. Baril, Rosillon, D., Willame, C., Angelo, M. G., Zima, J., van den Bosch, J. H., Van Staa, T., Boggon, R., Bunge, E. M., Hernandez-Diaz, S., and Chambers, C. D., “Risk of spontaneous abortion and other pregnancy outcomes in 15-25 year old women exposed to human papillomavirus-16/18 AS04-adjuvanted vaccine in the United Kingdom”, Vaccine, vol. 33, pp. 6884-91, 2015.
2016
R. J. Moon, Harvey, N. C., Curtis, E. M., de Vries, F., Van Staa, T., and Cooper, C., “Ethnic and geographic variations in the epidemiology of childhood fractures in the United Kingdom”, Bone, vol. 85, pp. 9-14, 2016.
A. Matthews, Herrett, E., Gasparrini, A., Van Staa, T., Goldacre, B., Smeeth, L., and Bhaskaran, K., “Impact of statin related media coverage on use of statins: interrupted time series analysis with UK primary care data”, Bmj, vol. 353, p. i3283, 2016.
S. D'Angelo, Coggon, D., Harris, E. C., Linaker, C., Sayer, A. A., Gale, C. R., Evandrou, M., Van Staa, T., Cooper, C., Walker-Bone, K., and Palmer, K. T., “Job dissatisfaction and the older worker: baseline findings from the Health and Employment After Fifty study”, Occup Environ Med, vol. 73, pp. 512-9, 2016.
E. Herrett, Williamson, E., Van Staa, T., Ranopa, M., Free, C., Chadborn, T., Goldacre, B., and Smeeth, L., “Text messaging reminders for influenza vaccine in primary care: a cluster randomised controlled trial (TXT4FLUJAB)”, BMJ Open, vol. 6, p. e010069, 2016.
2017
S. J. Ronaldson, Raghunath, A., Torgerson, D. J., and Van Staa, T., “Cost-effectiveness of antibiotics for COPD management: observational analysis using CPRD data”, ERJ Open Res, vol. 3, 2017.
K. T. Palmer, D'Angelo, S., Harris, E. C., Linaker, C., Gale, C. R., Evandrou, M., Syddall, H., Van Staa, T., Cooper, C., A. Sayer, A., Coggon, D., and Walker-Bone, K., “Frailty, prefrailty and employment outcomes in Health and Employment After Fifty (HEAF) Study”, Occup Environ Med, vol. 74, pp. 476-482, 2017.
D. C. Perry, Metcalfe, D., Costa, M. L., and Van Staa, T., “A nationwide cohort study of slipped capital femoral epiphysis”, Arch Dis Child, vol. 102, pp. 1132-1136, 2017.
K. T. Palmer, D'Angelo, S., Harris, E. C., Linaker, C., Sayer, A. A., Gale, C. R., Evandrou, M., Van Staa, T., Cooper, C., and Coggon, D., “Sleep disturbance and the older worker: findings from the Health and Employment after Fifty study”, Scand J Work Environ Health, vol. 43, pp. 136-145, 2017.
2018
S. Khalid, Calderon-Larranaga, S., Hawley, S., Ali, M. S., Judge, A., Arden, N., Van Staa, T., Cooper, C., Javaid, M. K., and Prieto-Alhambra, D., “Comparative anti-fracture effectiveness of different oral anti-osteoporosis therapies based on "real-world" data: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database”, Clin Epidemiol, vol. 10, pp. 1417-1431, 2018.
G. L. C. Ferreira, Marano, C., De Moerlooze, L., Guignard, A., Feng, Y., Y. Hahi, E., and Van Staa, T., “Incidence and prevalence of hepatitis B in patients with diabetes mellitus in the UK: A population-based cohort study using the UK Clinical Practice Research Datalink”, J Viral Hepat, vol. 25, pp. 571-580, 2018.
A. Pate, Barrowman, M., Webb, D., Pimenta, J. M., Davis, K. J., Williams, R., Van Staa, T., and Sperrin, M., “Study investigating the generalisability of a COPD trial based in primary care (Salford Lung Study) and the presence of a Hawthorne effect”, BMJ Open Respir Res, vol. 5, p. e000339, 2018.
2019
M. Nowakowska, Van Staa, T., Molter, A., Ashcroft, D. M., Tsang, J. Y., White, A., Welfare, W., and Palin, V., “Antibiotic choice in UK general practice: rates and drivers of potentially inappropriate antibiotic prescribing”, J Antimicrob Chemother, 2019.
V. Palin, Molter, A., Belmonte, M., Ashcroft, D. M., White, A., Welfare, W., and Van Staa, T., “Antibiotic prescribing for common infections in UK general practice: variability and drivers”, J Antimicrob Chemother, 2019.
S. Abtahi, Burden, A. M., Geusens, P., van den Bergh, J. P., Van Staa, T., and de Vries, F., “The Association of Oral Bisphosphonate Use With Mortality Risk Following a Major Osteoporotic Fracture in the United Kingdom: Population-Based Cohort Study”, J Am Med Dir Assoc, 2019.
E. Herrett, Gadd, S., Jackson, R., Bhaskaran, K., Williamson, E., Van Staa, T., Sofat, R., Timmis, A., and Smeeth, L., “Eligibility and subsequent burden of cardiovascular disease of four strategies for blood pressure-lowering treatment: a retrospective cohort study”, Lancet, 2019.
D. F. Carr, Francis, B., Jorgensen, A. L., Zhang, E., Chinoy, H., Heckbert, S. R., Bis, J. C., Brody, J. A., Floyd, J., Psaty, B. M., Molokhia, M., Lapeyre-Mestre, M., Conforti, A., Alfirevic, A., Van Staa, T., and Pirmohamed, M., “Genome-wide association study of statin-induced myopathy in patients recruited using the UK clinical practice research datalink”, Clin Pharmacol Ther, 2019.
J. S. Floyd, Bloch, K. M., Brody, J. A., Maroteau, C., Siddiqui, M. K., Gregory, R., Carr, D. F., Molokhia, M., Liu, X., Bis, J. C., Ahmed, A., Liu, X., Hallberg, P., Yue, Q. Y., Magnusson, P. K. E., Brisson, D., Wiggins, K. L., Morrison, A. C., Khoury, E., McKeigue, P., Stricker, B. H., Lapeyre-Mestre, M., Heckbert, S. R., Gallagher, A. M., Chinoy, H., Gibbs, R. A., Bondon-Guitton, E., Tracy, R., Boerwinkle, E., Gaudet, D., Conforti, A., Van Staa, T., Sitlani, C. M., Rice, K. M., van der Zee, A. H. Maitlan, Wadelius, M., Morris, A. P., Pirmohamed, M., Palmer, C. A. N., Psaty, B. M., and Alfirevic, A., “Pharmacogenomics of statin-related myopathy: Meta-analysis of rare variants from whole-exome sequencing”, PLoS One, vol. 14, p. e0218115, 2019.
A. Pate, Emsley, R., Ashcroft, D. M., Brown, B., and Van Staa, T., “The uncertainty with using risk prediction models for individual decision making: an exemplar cohort study examining the prediction of cardiovascular disease in English primary care”, BMC Med, vol. 17, p. 134, 2019.
2020
A. Pate, Van Staa, T., and Emsley, R., “An assessment of the potential miscalibration of cardiovascular disease risk predictions caused by a secular trend in cardiovascular disease in England”, BMC Med Res Methodol, vol. 20, p. 289, 2020.
C. Mistry, Palin, V., Li, Y., Martin, G. P., Jenkins, D., Welfare, W., Ashcroft, D. M., and Van Staa, T., “Development and validation of a multivariable prediction model for infection-related complications in patients with common infections in UK primary care and the extent of risk-based prescribing of antibiotics”, BMC Med, vol. 18, p. 118, 2020.
A. Pate, Emsley, R., and Van Staa, T., “Impact of lowering the risk threshold for statin treatment on statin prescribing: a descriptive study in English primary care”, Br J Gen Pract, vol. 70, pp. e765-e771, 2020.
A. Pate, Emsley, R., Sperrin, M., Martin, G. P., and Van Staa, T., “Impact of sample size on the stability of risk scores from clinical prediction models: a case study in cardiovascular disease”, Diagn Progn Res, vol. 4, p. 14, 2020.
A. Pate, Elliott, R. A., Gkountouras, G., Thompson, A., Emsley, R., and Van Staa, T., “The impact of statin discontinuation and restarting rates on the optimal time to initiate statins and on the number of cardiovascular events prevented”, Pharmacoepidemiol Drug Saf, 2020.
[Page last reviewed 6 April 2021]